本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Virax Biolabs Group Limited

0.9785
+0.00750.77%
盘后0.97850.00000.00%16:50 EDT
成交量:1.24万
成交额:1.20万
市值:424.86万
市盈率:-0.40
高:1.00
开:0.9700
低:0.9500
收:0.9710
数据加载中...
2025/01/30

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/21

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/13

SEC问询函

Form CORRESP - Correspondence
2023/06/14

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/03/28

SEC问询函

CORRESP [Cover] - Correspondence
2023/03/22

招股说明书

F-1 - Registration statement for certain foreign private issuers
2022/11/29

SEC问询函

CORRESP [Cover] - Correspondence
2022/11/21

招股说明书

F-1 - Registration statement for certain foreign private issuers
2022/08/12

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/07/01

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2022/06/30

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2022/06/28

SEC问询函

CORRESP [Cover] - Correspondence
2022/06/28

SEC问询函

CORRESP [Cover] - Correspondence
2022/06/27

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2022/06/24

SEC问询函

CORRESP [Cover] - Correspondence
2022/06/24

SEC问询函

CORRESP [Cover] - Correspondence
2022/06/24

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2022/06/21

SEC问询函

CORRESP [Cover] - Correspondence